A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.

Philippe Damier Bertrand DegosGiovanni CastelonovoMathieu AnheimIsabelle BenatruNicolas CarrièreOlivier ColinLuc DefebvreMarie DeverdalAlexandre EusebioVanessa FerrierCaroline GiordanaJean-Luc HouetoSeverine Le DilyMarie MonginClaire ThiriezChristine TranchantDenis RavelJean-Christophe Corvol Olivier RascolYehezkel Ben Ari

Published in: Movement disorders : official journal of the Movement Disorder Society (2024)

There was no evidence in this study that bumetanide has efficacy in improving motor symptoms of PD. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

double blind
placebo controlled
open label
clinical trial
phase ii
systematic review
randomized controlled trial